— Know what they know.
Not Investment Advice
Also trades as: 2616.HK (HKSE) · $vol 8M

CSPHF Earnings

CStone Pharmaceuticals
1W: +4.9% 1M: +10.4% 3M: +26.9% YTD: -15.4% 1Y: -24.5% 3Y: +51.0% 5Y: -32.0%
$0.76
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 52 · $1.2B mcap · 1.24B float · 0.0003% daily turnover · Short 71% of daily vol
Last Earnings 2026-08-27
EPS
¥-0.03 (US$-0.00)
▲ Beat +10.7%
Revenue
¥30M ($5M)
▲ Beat +49.7%
Next Earnings Qtr ending 2026-12-30 · date TBD
EPS Estimate
¥-0.42 (US$-0.06)
Range: ¥-0.42 - ¥-0.42
Revenue Estimate
¥179M ($27M)
1 analysts
1 USD = 6.70 CNY

Estimate vs Actual

Earnings Surprise History

7/19
EPS Beats
4/19
Revenue Beats
37%
EPS Beat Rate
21%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-10-01 quarter 2027-06-30 ¥-0.27 ¥-0.40 ▼ 0.13 ¥332,941,838 ¥220,024,996
2026-10-01 annual 2026-12-31 ¥-0.29 ¥-0.29 — ¥427,892,752 ¥427,749,145
2026-10-01 quarter 2028-12-30 ¥-0.12 ¥-0.19 ▼ 0.07 ¥249,840,568 ¥136,851,905
2026-10-01 annual 2027-12-31 ¥2.07 ¥2.07 — ¥2,658,785,330 ¥2,657,893,000
2026-10-01 quarter 2029-06-30 ¥— ¥-0.12 ▼ 0.12 ¥— ¥249,756,718
2026-10-01 quarter 2026-12-30 ¥-0.40 ¥-0.42 ▼ 0.02 ¥220,024,996 ¥178,828,065
2026-10-01 quarter 2028-06-30 ¥-0.09 ¥-0.03 ▲ 0.06 ¥102,167,141 ¥292,500,798
2026-10-01 annual 2028-12-31 ¥0.14 ¥0.14 — ¥988,328,565 ¥987,996,867
2026-09-29 quarter 2028-12-30 ¥-0.12 ¥-0.12 — ¥249,572,247 ¥249,840,568
2026-09-29 annual 2026-12-31 ¥-0.29 ¥-0.29 — ¥427,433,209 ¥427,892,752
2026-09-29 annual 2027-12-31 ¥2.07 ¥2.07 — ¥2,655,929,875 ¥2,658,785,330
2026-09-29 annual 2028-12-31 ¥0.14 ¥0.14 — ¥987,267,130 ¥988,328,565
2026-09-28 annual 2028-12-31 ¥0.14 ¥0.14 — ¥988,063,207 ¥987,267,130
2026-09-28 annual 2027-12-31 ¥2.07 ¥2.07 — ¥2,658,071,466 ¥2,655,929,875
2026-09-28 annual 2026-12-31 ¥-0.29 ¥-0.29 — ¥427,777,866 ¥427,433,209
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms